Scientific program | Symposia Home > Scientific program
Symposium I: Calcium Metabolism and Atherosclerosis Friday, September 12th (09:00–10:30) - Convention Hall A
Chairpersons : Hyun Ho Shin, Inkyu Lee
Hyun-Jai Cho
Seoul National University, Korea
S1-1
Molecular Regulator of Vascular Calcification in Atherosclerosis
Sung Hee Choi
Seoul National University, Korea
S1-2
Clinical: Vascular Calcification Imaging
Ian Reid
University of Auckland, New Zealand
S1-3
TBD


English Korean
Symposium Ⅱ: Treatment of Subclinical Atherosclerosis Friday, September 12th (13:20-15:20) - Convention Hall B
Chairpersons : Hong Kyu Lee, Young-Bae Park
Ki Hoon Han
University of Ulsan, Korea
S2-1
Statin for Primary Prevention in Subclinical Atherosclerosis
Jinkwon Kim
Cha University, Korea
S2-2
Antiplatelet Agent for Primary Prevention in Subclinical Atherosclerosis
Yun-Hyeong Cho
Myongji Hospital, Korea
S2-3
Nonmedical Intervention for Subclinical Atherosclerosis


English Korean
Symposium Ⅲ: Evidence-based Cardiovascular Disease Prediction and Prevention Friday, September 12th (15:40~17:40) - Convention Hall A
Chairpersons : Ho Young Son, Sung Chull Chae
Nathan D. Wong
University of California in Irvine, USA
S3-1
CVD Risk Stratification, Management of Dyslipidemia for Primary and Secondary Prevention USA
Chang Hee Jung
University of Ulsan, Korea
S3-2
CVD Risk Stratification, Management of Dyslipidemia for Primary and Secondary Prevention Korea
Ken-ichi Hirata
Kobe University, Japan
S3-3
CVD Risk Stratification, Management of Dyslipidemia for Primary and Secondary Prevention Japan
TBD S3-4
CVD Risk Stratification, Management of Dyslipidemia for Primary and Secondary Prevention China


English Korean
Symposium Ⅳ: Nutrition and Inflammation
       
Friday, September 12th (15:40~17:40) - Convention Hall B
Chairpersons : Hyun-Sook Kim, Yangha Kim
Jong Ho Lee
Yonsei University, Korea
S4-1
Verification of Metabolic Disease Related-new Nutritional Metabolites Based on Clinical Nutrigenetic and Metabolomic Technology
Won Ho Kim
Korea Centers for Disease Control and Prevention, Korea
S4-2
The Role of Activation Transcription Factor 3 (ATF3) on the Progression of Type 2 Diabetes and Its Complication
Gary Sweeney
York University, Canada
S4-3
Recent Insights on Mechanisms of Cardiovascular Complications in Type 2 Diabetes


English Korean
Symposium Ⅴ: Immune Cells and Autophagy in Metabolic Disease Saturday, September 13th (08:40-10:40) - Convention Hall A
Chairpersons : Hun Taeg Chung, Youngmi Kim
Young Mi Park
Ewha Womans University, Korea
S5-1
Macrophage in the Pathogenesis of Atherosclerosis
Cheolho Cheong
University of Montreal, Canada
S5-2
The Role of Subsets of Vascular Dendritic Cell in Atherosclerosis
Clinton Robbins
University of Toronto, Canada
S5-3
The Development of Myeloid Responses in Vascular Health and Disease
Goo Yaeg Oh
Ewha Womans University, Korea
S5-4
ROS Induced Autophagy in the Pathogenesis of Atherosclerosis
Myung-Shik Lee
Sungkyunkwan University, Korea
S5-5
Autophagy in the Metabolic Disease
Panels : Chi Dae Kim, Sang-Hak Lee, Hae-Young Lee, Jin Han


English Korean
Symposium Ⅵ: Promising Anti-atherosclerotic Approaches on Coronary Disease Saturday, September 13th (14:00-15:30) - Convention Hall A
Chairpersons : Sang Hong Baek, Kyong Soo Park
Sang Hyun Kim
Seoul National University, Korea
S6-1
Lipid Modulations Except Statin and Atherosclerosis
Hae-Young Lee
Seoul National University, Korea
S6-2
New Evolving Anti-inflammatory Agents on Atherosclerosis
Cheol Whan Lee
University of Ulsan, Korea
S6-3
Antiplatelet Drugs for Prevention of Atherothrombotic Event-Do We Need New Options?


English Korean
Symposium Ⅶ: Diabetes and Atherosclerosis
       
Saturday, September 13th (15:50-17:30) - Convention Hall A
Chairpersons : Hong-Seog Seo, Joong-Yeol Park
Kwanpyo Koh
Jeju National University, Korea
S7-1
Conventional Oral Antidiabetic Agents and Cardiovascular Disease
Eun-Jung Rhee
Sungkyunkwan University, Korea
S7-2
Thiazolidinedione and Cardiovascular Disease
Soo Lim
Seoul National University, Korea
S7-3
Incretin-based Therapy and Cardiovascular Disease


English Korean
Organizations-KSLA Joint Symposium: Future of Clinical Trial and Research in Korea Saturday, September 13th (14:00-15:30) - Convention Hall B
Chairperson : Donghoon Choi
Dong-Ho Shin
Yonsei University, Korea
JS-1
How to Deal with Obstacles of Clinical Research
MIN SOO PARK
Yonsei University, Korea
JS-2
What Researchers Need to Know about Conflict of Interest
Ki Hwan Choi
Ministry of Food and Drug Safety, Korea
JS-3
Clinical Trial for New Drug Approval in Korea
Panels : Jaetaek Kim, Jin Kim, Kichang Nam, Young-Jack Lee


English Korean
Presentation for Projects Funded by KSLA(Korean)
             
Saturday, September 13th (15:50-17:30) - Convention Hall B
Chairpersons : Hak Chul Jang, Jin Han
Woo Je Lee
University of Ulsan, Korea
P-1
The Validation of Usefulness of Serum Apolipoprotein B/apolipoprotein A1 Ratio in Detecting the Subjects with Metabolic Syndrome in a Korean Population
Jee Hyun An
Korea University, Korea
P-2
Effects of Thyroid Hormone Withdrawal on Metabolic and Cardiovascular Parameters During Radioactive Iodine Therapy in Differentiated Thyroid Cancer
Woo-Young Chung
Seoul National University, Korea
P-3
The Serum Concentration of MicroRNA-33 and Its Changes by Statin Treatment in High LDL Cholesterolemic Patients
Jae-Hoon Choi
Hanyang University, Korea
P-3
Identification of Whole Immune Cell Population in Normal and Atherosclerotic Mouse Aorta


English Korean
Basic Research Committee Workshop: New Hope for Vascular Biology(Korean) Friday, September 12th (09:00-10:30) - Convention Hall B
Chairpersons : Jeong Euy Park, Chi Dae Kim
Injune Kim
Korea Advanced Institute of Science and Technology, Korea
BRCW-1
The Role of Sox17 in the Vascular Health and Disease
Chung-Hyun Cho
Seoul National University, Korea
BRCW-2
Angiopoietin 2 Mediates High Glucose-induced Pericyte Apoptosis in a Integrin Dependent Manner
Kyu-Tae Kang
Duksung Women’s University, Korea
BRCW-3
Building Blood Vessels Using Human Vasculogenic Cells: Clinical Application
Panels : Nari Kim, Jae Ryong Kim, Jae-Hoon Choi


English Korean
Oral Presentation 1, 2
             
Friday, September 12th (13:20-15:20) - Convention Hall A
Chairpersons : Moon Suk Nam, Youngkeun Ahn
TBD OP-1
Oral Presentation 1
TBD OP-2
Oral Presentation 1
TBD OP-3
Oral Presentation 2
TBD OP-4
Oral Presentation 2


English Korean